Ignite Creation Date:
2024-07-17 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06498518
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-02
Brief Title:
A Trial of Gemcitabine Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
Sponsor:
Karen Carty
Organization:
University of Glasgow
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-02
First Submit QC Date:
None
Study First Post Date:
2024-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-09
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL